Generated by AI
NeuroPace, Inc. is a medical device company focused on brain-responsive neuromodulation for people living with epilepsy. Its core RNS System is an implantable platform designed to detect abnormal brain activity and deliver targeted stimulation in response, helping physicians manage medically refractory focal epilepsy. The company’s product portfolio includes the RNS neurostimulator, depth and cortical strip leads, and accompanying patient monitoring and programming tools that support long-term therapy and remote clinical review. NeuroPace serves hospitals and epilepsy care centers, with its technology used in specialized neurology settings where individualized treatment is critical. The company operates in the neuromodulation and epilepsy treatment markets, where it plays a distinct role by combining continuous brain signal monitoring with responsive therapy in a single commercial system.
Website455 North Bernardo Avenue
Mountain View, CA, 94043
United States
The latest articles about NPCE.
Summary of Nov 13's posts. Generated by AI.
No summary yet.
No summary yet.
Summary of May 17's posts. Generated by AI.
No summary yet.
Summary of Nov 13's posts. Generated by AI.
Investors talking about NPCE also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.